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Abstract
Age-associated	 loss	of	muscle	mass	and	function	(sarcopenia)	has	a	profound	effect	
on	the	quality	of	life	in	the	elderly.	Our	previous	studies	show	that	CuZnSOD	deletion	
in	mice	(Sod1−/−	mice)	recapitulates	sarcopenia	phenotypes,	including	elevated	oxida-
tive	 stress	and	accelerated	muscle	atrophy,	weakness,	 and	disruption	of	neuromus-
cular	junctions	(NMJs).	To	determine	whether	deletion	of	Sod1 initiated in neurons in 
adult	mice	is	sufficient	to	induce	muscle	atrophy,	we	treated	young	(2-	to	4-month-old)	
Sod1flox/SlickHCre	mice	with	 tamoxifen	 to	generate	 i-mn-Sod1KO	mice.	CuZnSOD	
protein	was	 40-50%	 lower	 in	 neuronal	 tissue	 in	 i-mn-Sod1KO	mice.	Motor	 neuron	
number	in	ventral	spinal	cord	was	reduced	28%	at	10	months	and	more	than	50%	in	
18-	to	22-month-old	i-mn-Sod1KO	mice.	By	24	months,	22%	of	NMJs	in	i-mn-Sod1KO	
mice	displayed	a	complete	 lack	of	 innervation	and	deficits	 in	specific	 force	 that	are	
partially	reversed	by	direct	muscle	stimulation,	supporting	the	loss	of	NMJ	structure	
and	function.	Muscle	mass	was	significantly	reduced	by	16	months	of	age	and	further	
decreased	at	24	months	of	age.	Overall,	our	findings	show	that	neuronal-specific	dele-
tion	of	CuZnSOD	is	sufficient	to	cause	motor	neuron	loss	in	young	mice,	but	that	NMJ	
disruption,	muscle	atrophy,	and	weakness	are	not	evident	until	past	middle	age.	These	
results suggest that loss of innervation is critical but may not be sufficient until the 
muscle reaches a threshold beyond which it cannot compensate for neuronal loss or 
rescue	additional	fibers	past	the	maximum	size	of	the	motor	unit.
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1  |  INTRODUC TION
Age-associated	loss	of	skeletal	muscle	mass	and	function,	or	sarco-
penia,	is	a	major	determinant	of	reduced	quality	of	life	and	frailty	in	
the	elderly.	While	the	pathogenesis	of	sarcopenia	is	multifactorial,	
a	progressive	increase	in	age-associated	oxidative	stress	is	consid-
ered a major contributor to muscle impairment in elderly humans 
(Barker	&	Traber,	2007)	as	well	as	in	experimental	rodent	models	
(Broome	et	al.,	2006;	Vasilaki	et	al.,	2007).	In	a	series	of	previous	
studies,	we	and	others	have	reported	that	mice	lacking	the	super-
oxide	scavenger	Copper	Zinc	Superoxide	Dismutase	(Sod1−/−	mice)	
show	a	very	high	level	of	oxidative	stress	in	all	tissues,	associated	
with a number of phenotypes associated with aging including 
hearing	loss,	cataracts,	skin	thinning,	delayed	wound	healing,	and	
an	accelerated	sarcopenia	phenotype	(Deepa	et	al.,	2019;	Muller	
et	 al.,	 2006;	 Snider,	Richardson,	 Stoner,	&	Deepa,	 2018).	 In	 par-
ticular,	 hind	 limb	 skeletal	 muscle	 in	 Sod1−/−	 mice	 exhibits	 mito-
chondrial	abnormalities,	degeneration	of	neuromuscular	junctions	
(NMJs)	and	loss	of	innervation,	and	loss	of	contractile	force	during	
early adulthood that is similar to the hind limb muscle phenotype 
in	old	wild-type	mice	(Brooks	&	Faulkner,	1991,	1994;	Jang	et	al.,	
2010;	 Larkin	 et	 al.,	 2011).	 The	 clear	 changes	 in	 motor	 neuron	
and neuromuscular junction morphology point to a coordinated 
role	of	motor	neurons	and	skeletal	muscle	in	the	development	of	
sarcopenia.
To	 delineate	 the	 relative	 roles	 of	 pre-	 and	 postsynaptic	 redox	
imbalance	 in	 sarcopenia,	we	previously	generated	mice	with	a	ge-
netic deletion of Sod1	 specifically	 targeted	 to	 skeletal	muscle	 and	
surprisingly	found	that	CuZnSOD	deletion	targeted	to	skeletal	mus-
cle does not induce loss of muscle mass even in older adult mice 
(up	to	16–17	months)	and	contractile	dysfunction	is	only	marginally	
reduced	 (Zhang	et	 al.,	 2013).	 This	 result	 suggests	 that	 the	muscle	
is	 not	 the	 sole	 effector	 of	 the	 sarcopenia	 phenotype.	Conversely,	
to determine whether the muscle decline associated with aging is 
initiated	by	redox	changes	in	motor	neurons,	we	generated	a	mouse	
model	in	which	the	human	CuZnSOD	gene	was	specifically	targeted	
to neurons on an Sod1−/−	background	(SynTgSod1−/−	mice)	(Sakellariou	
et	al.,	2014).	In	these	“rescue”	mice,	the	neuron-specific	expression	
of Sod1	prevented	the	muscle	atrophy,	NMJ	degeneration,	and	mus-
cle	weakness	phenotypes	that	occur	in	the	Sod1−/− mice suggesting 
that	the	redox	balance	in	motor	neuron	is	critical	mediator	of	muscle	
innervation	and	atrophy	(Sakellariou	et	al.,	2014).	In	support	of	this,	
ablation	 of	 the	 antioxidant	 enzyme	 glutathione	 peroxidase-4	 spe-
cifically in motor neurons also causes muscle atrophy and paralysis 
in	mice	(Chen,	Hambright,	Na,	&	Ran,	2015).	Thus,	we	hypothesized	
that reduction of Sod1 in motor neurons would be sufficient to in-
duce	muscle	impairment	in	wild-type	mice.
To	 test	 this	 hypothesis,	 we	 previously	 generated	 mice	 with	 a	
constitutive	embryonic	neuron-specific	deletion	of	Sod1 using the 
nestin-cre	 (nSod1−/−	mice)	 promoter	 (Sataranatarajan	 et	 al.,	 2015).	
Surprisingly	these	mice	did	not	show	significant	atrophy	of	gastroc-
nemius	muscles	even	at	20	months	of	age,	although	mild	contractile	
dysfunction	 and	 signs	 of	 denervation	were	 evident.	We	 hypothe-
sized	that	the	deletion	of	Sod1	using	the	nestin-cre	was	not	suffi-
cient to induce a phenotype or that the deletion during embryonic 
development may induce compensatory effects that altered the ef-
fect of motor neuron deletion in the mice at later ages. To address 
these possibilities and to measure the effect of Sod1 deficiency in 
motor	neurons	on	muscle	mass	and	function	induced	in	adult	mice,	
we generated a mouse model with inducible deletion of Sod1	(i-mn-
Sod1KO)	 targeted	by	a	neuron-specific	cre	 recombinase	driven	by	
the Thy1 promoter. The findings presented here show that neuron 
deletion of Sod1 in adult mice does indeed result in atrophy and con-
tractile dysfunction of the gastrocnemius muscle as well as a disrup-
tion	of	NMJ	morphology	in	older	mice.	Together	these	data	support	
a	critical	role	of	motor	neurons	in	initiating	muscle	atrophy,	but	also	
suggest	it	is	a	progressive	effect	that	requires	time,	intrinsic	effects	
of	aging	on	tissue	function	to	develop,	or	an	exhaustion	of	the	ability	
of neurons to compensate for neuronal deficits.
2  |  MATERIAL S AND METHODS
2.1  |  Generation of motor neuron deficient Sod1 
mice (i-mn-Sod1KO)
The	SlickH	Cre	mice	were	obtained	from	Jackson	Laboratories	(Bar	
Harbor,	 ME	 Stock	 #	 012708).	 These	 mice	 have	 previously	 been	
shown	to	induce	expression	of	Cre	recombinase	in	motor	neurons	in	
the	spinal	cord	without	expression	in	non-neuronal	tissues,	allowing	
us to generate a motor neuron deletion without any effect on mus-
cle Sod1	(Young	et	al.,	2008).	Sod1flox/flox mice were generated in our 
laboratory	and	have	previously	been	described	(Zhang	et	al.,	2013).	
Both	 strains	 are	 maintained	 on	 a	 C57Bl6	 background.	 The	 i-mn-
Sod1KO	mice	were	generated	by	two-step	cross-breeding	between	
Sod1flox/flox	 and	 SlickH	 Cre	mice.	 Sod1floxflox;SlickHCre	 (i-mn-Sod1KO)	
and	 littermate	Sod1flox/flox;	SlickHwt controls were used for the study. 
Tamoxifen	 was	 dissolved	 in	 corn	 oil	 (10	 mg/ml)	 and	 administered	
to	 2-	 to	 4-month-old	 Sod1floxflox;SlickHCre	 (i-mn-Sod1KO)	 and	 litter-
mate	Sod1flox/flox;	SlickHwt controls by intraperitoneal injection for two 
rounds	of	5	consecutive	days	(60	mg/kg	body	weight).	Mice	were	sac-
rificed	at	various	ages	as	noted	in	each	particular	dataset.	Previously,	
we	found	that	whole-body	deletion	of	Sod1	in	mice	(Sod1−/−)	results	
in	 a	 lower	 body	 weight	 (15-20%)	 and	 accelerated	 loss	 of	 muscle	
mass	with	age	that	mimics	the	sarcopenia	phenotype	(Muller	et	al.,	
2006;	Sakellariou	et	al.,	2011).	In	 i-mn-Sod1−/−	mice,	we	did	not	see	
any	change	in	body	weight	compared	with	age-matched	tamoxifen-
treated	control	mice	(data	not	shown).
K E Y W O R D S
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2.2  |  Western blotting
Western	 blot	 analysis	 was	 performed	 as	 previously	 described	
(Bhaskaran	et	al.,	2018).	Protein	bands	were	detected	by	ECL	rea-
gent	using	G-Box	(Syngene),	and	the	band	intensity	was	measured	by	
NIH	image	J.	The	following	primary	antibodies	were	used:	CuZnSOD	
(Enzo),	β-actin	(Sigma)	VDAC	(Cell	Signaling),	MURF1	(Santa	Cruz).
2.3  |  Immunofluorescence
Motor neuron count and area in lumbar region of spinal cord were 
determined	as	described	previously	 (Piekarz	et	al.,	2020).	Sections	
were	 stained	with	NeuN	 antibody	 (Cell	 Signaling	 Technology)	 fol-
lowed	by	Alexa	Fluor®488	F(ab)2	Fragment	of	Goat	Anti-Rabbit	IgG	
(H	 +	 L)	 antibody.	 Images	 were	 taken	with	 Nikon	 Eclipse	 confocal	
microscope	and	analyzed	with	Nikon	elements	c	 image	acquisition	
software.	NeuN	is	a	protein	that	 is	present	 in	nucleus	and	perinu-
clear	cytoplasm	of	neurons	and	 is	widely	used	as	neuronal	marker	
(Gusel'nikova	&	Korzhevskiy,	2015).
2.4  |  Muscle function analyses
Gastrocnemius	(GTN)	muscle	contractile	properties	were	measured	in 
situ	as	previously	described	by	(Larkin	et	al.,	2011).	Briefly,	whole	GTN	
muscle	was	isolated	in	anesthetized	mice,	and	the	distal	tendon	was	
severed	and	secured	to	the	lever	arm	of	a	servomotor	(model	305B;	
Aurora	Scientific	Inc.).	The	muscle	was	activated	by	stimulation	of	the	
tibial nerve using a bipolar platinum wire electrode. The voltage of 
single 0.2 ms stimulation pulses and subsequently muscle length were 
adjusted	to	give	a	maximum	isometric	twitch.	With	the	muscle	held	at	
optimal	length	for	maximum	twitch	force	(Lo),	300	ms	trains	of	pulses	
were	applied	at	increasing	stimulation	frequencies	until	the	maximum	
isometric	 tetanic	 force	 (Po)	was	achieved.	Subsequently,	 a	 cuff	 elec-
trode	was	placed	around	the	proximal	and	distal	ends	of	the	muscle	for	
direct	muscle	stimulation,	and	the	Po	was	once	again	determined.	GTN	
muscle	fiber	length	(Lf)	was	calculated	by	multiplying	Lo by 0.45. Total 
fiber	cross-sectional	area	(CSA)	was	calculated	by	dividing	the	muscle	
mass	(mg)	by	the	product	of	Lf	(mm)	and	the	density	of	mammalian	skel-
etal	muscle,	1.06	g/cm2.	Specific	Po	(N/cm
2)	was	calculated	by	dividing	
Po	by	total	fiber	CSA	for	each	muscle	(Brooks	&	Faulkner,	1988).
2.5  |  Immunofluorescence analysis of NMJS
Small	 fiber	bundles	 (10–20	muscle	 fibers)	or	35	mm	 thick	 longitu-
dinal	 sections	 from	GTN	muscles	were	prepared	 for	NMJ	analysis	
as	 described	 previously	 (Macpherson,	 Farshi,	 &	 Goldman,	 2015).	
Briefly,	muscles	were	 fixed	for	15	min	at	 room	temperature	 in	4%	
paraformaldehyde,	rinsed	with	PBS,	cryoprotected	with	a	gradient	
of	30%	sucrose,	 frozen	 in	OTC	 (Triangle	Biomedical	Sciences)	 and	
cut	into	longitudinal	sections.	Bundles	of	muscle	fibers	were	teased	
from	 some	 of	 the	 remaining	muscle	 blocks	 after	 being	 thawed	 in	
PBS.	Muscle	sections	and	fiber	bundles	were	blocked	for	30	min	in	
PBS	containing	5%	donkey	serum	and	1%	triton	X-100.	To	visualize	
axons	and	presynaptic	terminals,	muscles	were	incubated	overnight	
at	 4°C	 with	 rabbit	 anti-βIII-tubulin	 antibody	 (1:1000;	 BioLegend,	
802001)	 and/or	 mouse	 anti-SV2	 antibody	 (1:50;	 Developmental	
Studies	Hybridoma	Bank,	SV2).	After	 rinsing	 in	PBS	a	minimum	of	
three	times	to	remove	excess	primary	antibodies,	muscles	were	in-
cubated	 with	 Alexa	 Fluor	 594-conjugated	 α-bungarotoxin	 (α-Btx;	
1:2000;	 Thermo	 Fisher,	 B-13423)	 to	 label	 acetylcholine	 receptors	
on	 the	postsynaptic	muscle	membrane.	 Following	 incubation	with	
a	combination	of	rabbit	and	mouse	Alexa	488	secondary	antibodies	
(1:2000	Thermo	Fisher,	A11034	and	A21202),	slides	were	washed,	
coverslips	 applied	 and	 the	 slides	 were	 examined	 with	 either	 an	
Olympus	FV1000	or	Nikon	A1	laser	scanning	confocal	microscope.	
Quantitative	analysis	of	NMJ	structure	was	done	by	two	different	
individuals	using	software	associated	with	the	Olympus	FV1000	mi-
croscope	or	with	ImageJ.	At	least	4	muscles	were	analyzed	for	each	
group	and	approximately	100	endplates	were	scored	in	each	muscle.	
Depending	on	the	extent	of	overlap	of	βIII-tubulin/SV2	with	α-Btx,	
endplates	 were	 scored	 as	 completely	 innervated	 (100%	 overlap),	
partially	denervated	(∼10%–80%	overlap)	or	completely	denervated	
(Jang	 et	 al.,	 2010;	Macpherson	 et	 al.,	 2015).	Differences	 for	 each	
classification	 of	 innervation	 status	 between	 experimental	 groups	
were	 established	 by	 analysis	 of	 variance	 (ANOVA)	with	 individual	
differences	determined	by	Tukey's	post	hoc	tests.
2.6  |  Simultaneous high-resolution 
respirometry and fluorometry measurements
Skeletal	muscle	 fibers	were	permeabilized	as	previously	described	
(Ahn	et	al.,	2019)	and	used	for	simultaneous	measurement	of	oxy-
gen	consumption	rate	(OCR)	and	mitochondrial	hydrogen	peroxide	
production	using	the	Oxygraph-2k	(O2k,	OROBOROS	Instruments).	
Data	for	both	OCR	and	rates	of	H2O2	generation	were	normalized	by	
milligrams of muscle bundle wet weights.
2.7  |  Measurement of F2-isoprostanes and protein 
carbonyls in skeletal muscle tissue
F2 isoprostanes isolated from 150 mg of tissues were measured 
using	 gas-chromatography	 coupled	 with	 mass	 spectrophotometry	
[GC-MS]	 as	 described	 previously	 (Ahn	 et	 al.,	 2019).	 The	 level	 of	
F2-isoprostanes	 in	muscle	 tissues	was	 calculated	based	on	 the	 in-
ternal	 standard,	 and	 the	 amount	 was	 expressed	 as	 nanograms	 of	
8-Iso-PGF2α,	 per	 gram	 of	muscle	 tissue.	 Protein	 carbonylation	 in	
gastrocnemius muscle was determined as we have previously de-
scribed,	using	25	mg	of	frozen	tissue	(Qaisar	et	al.,	2018).	The	car-
bonyl	content	of	the	protein	samples	was	expressed	as	the	ratio	of	
FTC	fluorescence	(carbonyls)	to	Coomassie	blue	absorption	(protein	
concentration).
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2.8  |  Quantitative real-time PCR
Total	RNA	was	extracted	using	the	Trizol)	from	30	mg	of	frozen	GTN	
muscle	 as	 described	 before	 (Sataranatarajan	 et	 al.,	 2015).	 Primers	
used are shown in Table 1.
3  |  RESULTS
3.1  |  Motor neuron deletion of the Sod1 gene 
reduces CuZnSOD protein expression in motor 
neurons
The	SlickH	Cre	mouse	was	originally	developed	as	a	model	to	de-
lete	genes	in	motor	neurons,	while	also	simultaneously	labeling	the	
neurons	with	YFP.	When	crossed	to	mice	carrying	the	Sod1	floxed	
allele	 that	we	had	previously	generated	 (Zhang	et	al.,	2013),	 this	
Cre	mouse	model	allows	us	to	achieve	deletion	of	the	mouse	Sod1 
gene	under	 tamoxifen	 induction	of	Cre	 recombinase	 targeted	by	
the	Thy1	promoter	to	all	motor	neurons,	along	with	motor	neuron	
targeted	expression	of	YFP	in	the	same	cells	(i-mn-Sod1KO	mice).	
It should be noted that while we have targeted motor neurons with 
this	model,	the	expression	is	not	restricted	to	only	motor	neurons.	
Figure	1	(panels	a	and	b)	shows	the	effect	of	tamoxifen	induction	
of Sod1	deletion	initiated	in	2-	to	4-month-old	mice	on	CuZnSOD	
expression	in	neuronal	tissue	(brain,	spinal	cord,	and	sciatic	nerve)	
and	 non-neuronal	 (GTN	muscle)	 tissues	 from	 young	 (10	months)	
and	 old	 (18-22	 months)	 control	 (Sod1floxflox;SlickHwt)	 and	 i-mn-
Sod1KO	(Sod1floxflox;SlickHCre)	mice.	At	10	months	of	age	(6-8	months	
post-tamoxifen),	CuZnSOD	protein	 expression	 is	 significantly	 re-
duced	in	brain	(~68%),	spinal	cord	(~51%),	and	sciatic	nerve	(~41%)	
in i-mn-Sod1KO	mice,	compared	with	age-matched	wild-type	con-
trol	mice,	while	CuZnSOD	protein	 expression	 in	 skeletal	muscle,	
spleen	 (Figure	 S4),	 and	 liver	 (data	 not	 shown)	 is	 unchanged.	 At	
18–20	months	 of	 age,	 CuZnSOD	 protein	 expression	 remains	 re-
duced	in	brain	(37%),	spinal	cord	(~36%),	and	sciatic	nerve	(~53%)	
in i-mn-Sod1KO	 mice	 compared	 with	 age-matched	 control	 mice	
while	 the	expression	 in	GTN	muscle	 is	not	 reduced.	 It	 should	be	
noted	that	the	Western	blot	analysis	 is	 from	tissue	homogenates	
that	are	composed	of	multiple	cell	 types,	 some	of	which	will	not	
express	the	Cre	recombinase	and	thus	will	not	display	deletion	of	
Sod1.	Thus,	we	expect	to	see	only	a	partial	reduction	by	Western	
blot even though the actual reduction in the motor neurons is pre-
dicted to be more complete. The reduction of Sod1 in neuronal 
tissues does not result in a compensatory increase in the protein 
level	of	the	mitochondrial	form	of	superoxide	dismutase	(MnSOD)	
(data	not	shown).	To	further	confirm	the	impact	of	the	deletion	of	
Sod1 in i-mn-Sod1KO	mice,	we	 sectioned	 the	 lumbar	 spinal	 cord	
from	control,	i-mn-Sod1KO,	and	Sod1−/− mice and stained with an-
tibodies	specific	for	CuZnSOD	and	NeuN.	As	shown	in	Figure	1c,	
control	mice	show	clear	co-localization	of	CuZnSOD	and	NeuN	in	
the spinal cord that is absent in sections from the i-mn-Sod1KO	or	
in Sod1−/−	mice,	supporting	the	deletion	of	Sod1 in motor neurons 
in the i-mn-Sod1KO	mouse	model.	The	Slick	H	Cre	model	 is	also	
expressed	in	sensory	neurons	in	the	spinal	cord	but	we	would	not	
expect	that	to	alter	the	muscle	phenotype	we	are	investigating	in	
this	study.	Motor	neurons	in	the	cortex	are	also	targeted	for	Sod1 
deletion	as	indicated	by	the	reduction	in	CuZnSOD	expression	in	
brain. The potential impact of cortical deletion of Sod1,	while	po-
tentially	interesting,	is	beyond	the	scope	of	our	study.
TA B L E  1   List	of	QPCR	primers
Gene Primer sequence
Atrogin-1
F AACCGGGAGGCCAGCTAAAGAACA
R TGGGCCTACAGAACAGACAGTGC
AChR-α
F ACCTGGACCTATGACGGCTCT
R AGTTACTCAGGTCGGGCTGGT
ATPase6
F CACAACACTAAAGGACGAACCT
R GGGATGGCCATGGCTAGGTTTA
COX2
F ATGGCCTACCCATTCCAACT
R CGGGGTTGTTGATTTCGTC
Rieske
F TGGTCTCCCAGTTTGTTTCC
R GCAGCTTCCTGGTCAATCTC
SDHA
F CAGAAGTCGATGCAGAACCA
R CGACCCGCACTTTGTAATCT
NDUF3
F CTGTGGCAGCACGTAAGAAG
R ACTCATCAAGGCAGGACACC
18SRNA
F GTGGAGCGATTTGTCTGGTT
R CCC	ACT	GTG	TGC	ATT	CCA	GAT	
TGG
MURF1
F GAGAACCTGGAGAAGCAGCT
R CCGCGGTTGGTCCAGTAG
LC3
F TTGGTCAAGATCATCCGGC
R GCTCACCATGCTGTGCTGG
p62
F AGGCGCACTACCGCGAT
R CGTCACTGGAAAAGGCAACC
Bnip3
F GCTCCCAGACACCACAAGAT
R TGAGAGTAGCTGTGCGCTTC
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3.2  |  Motor neuron ablation of Sod1 reduces the 
number and area of alpha motor neurons
As	shown	 in	Figure	2a,b,	 the	number	of	alpha	motor	neurons	pre-
sent	 in	 the	 lumbar	 spinal	 cord	 from	 18-	 to	 22-month-old	 control	
mice	as	measured	by	NeuN	staining	 is	 reduced	by	30%	compared	
with	10-month-old	 control	mice.	The	 loss	of	 alpha	motor	neurons	
is greater in i-mn-Sod1−/−	mice,	reaching	~50%	fewer	motor	neurons	
in old i-mn-Sod1−/− mice compared with old control mice. In addition 
to	a	loss	in	motor	neuron	number,	the	area	of	the	motor	neurons	in	
the older i-mn-Sod1−/−	mice	is	approximately	40%	smaller	compared	
with	age-matched	wild-type	mice	as	shown	in	Figure	2c.	These	find-
ings suggest the preferential loss of larger motor neurons in the i-
mn-Sod1−/−	mice.	By	age	24	months,	the	i-mn-Sod1−/− mice also show 
dramatic	clasping	behavior	when	suspended	by	the	tail,	a	classic	in-
dicator	of	motor	neuron	degeneration	(Figure	2d).	It	is	possible	that	
this phenotype is also partially induced by loss of Sod1 in proprio-
ceptive sensory neurons in the i-mn-Sod1KO	mice.
3.3  |  i-mn-Sod1KO mice show an increase in 
neuromuscular junction degeneration that occurs 
later in life
We	have	previously	reported	a	dramatic	increase	in	denervated	neu-
romuscular	junction	(NMJs)	and	fragmentation	of	acetylcholine	recep-
tors in hind limb muscle from the Sod1−/− mice that is present even in 
young adult Sod1−/−	mice	 (Jang	et	 al.,	 2010).	We	hypothesized	 that	
motor	 neuron	 deletion	 of	 CuZnSOD	 expression	 would	 alter	 motor	
neuron function and that would be sufficient to cause the disruption 
of	NMJ	structure	and	function.	To	test	this	hypothesis,	we	examined	
the	NMJ	structure	of	the	GTN	muscle	using	immunofluorescent	stain-
ing	techniques	(Figure	3a)	in	i-mn-Sod1KO	and	control	mice	through-
out	the	lifespan.	Figure	3b	shows	the	results	of	quantitative	analysis	
of	 the	 extent	 of	 overlap	 between	 pre-	 and	 postsynaptic	 structures.	
In	 control	 mice,	 nearly	 100%	 of	 the	 NMJs	 show	 complete	 overlap	
between	nerve	terminals	and	motor	endplates	out	to	18	months.	By	
24	months,	close	to	20%	of	NMJs	in	control	muscles	are	partially	in-
nervated	and	5%	are	fully	denervated.	In	contrast,	in	muscles	of	i-mn-
Sod1KO	mice,	~10%	of	NMJs	were	partially	denervated	by	18	months,	
and	by	24	months	this	number	had	increased	to	45%	with	only	33%	
±4%	 (SD)	of	 the	NMJs	 remaining	 fully	 innervated.	 It	 is	 important	 to	
note that even at 24 months of age the i-mn-Sod1KO	mice	only	have	
22%	of	the	endplates	fully	denervated.	Consistent	with	the	histologi-
cal evidence of denervation we observed a modest but significant in-
crease	in	transcript	levels	of	the	alpha	subunit	of	nAChR	(Figure	3c).
3.4  |  Age-associated skeletal muscle atrophy is 
accelerated in i-mn-Sod1KO mice
Figure	4	shows	the	effect	of	CuZnSOD	deletion	on	GTN	muscle	mass.	
Muscle mass is not different between control and i-mn-Sod1KO	
mice	up	to	11	months	of	age	in	males	or	females.	There	is	a	24%	loss	
in	GTN	muscle	mass	relative	to	body	mass	in	older	(16–22	months)	
compared	with	young	adult	(9–11	months)	female	control	mice	and	
an	additional	30%	loss	 in	muscles	from	16-	to	22-month-old	 i-mn-
Sod1KO	mice	compared	with	age-matched	female	controls.	For	com-
parison,	 in	a	previous	study	we	reported	a	42%	difference	 in	GTN	
muscle	mass	relative	to	body	mass	in	20-month-old	female	wild-type	
and Sod1−/−	mice	(Muller	et	al.,	2006).	In	male	mice,	GTN	muscle	mass	
is	18%	lower	in	22-	to	26-month-old	versus	6-	to	11-month-old	con-
trol	mice	and	there	is	a	51%	loss	in	i-mn-Sod1KO	male	mice	versus	
control	at	16-22	months	and	30%	difference	between	these	groups	
at	24–26	months.
In addition to the accelerated onset and severity of atrophy in 
GTN	muscles,	masses	of	EDL,	soleus,	TA,	and	Quad	muscles	show	
an	acceleration	of	age-associated	atrophy.	No	differences	were	ob-
served	between	male	and	female	mice	for	muscle	mass	normalized	
for	body	mass	at	any	age	for	either	strain	of	mice.	Thus,	data	from	
males	and	females	were	pooled	and	are	shown	in	Figure	S1.	These	
data	 show	 that	 for	 control	mice,	muscle	mass	 is	 not	 different	 be-
tween	11	months	and	16	months	for	EDL,	soleus,	TA	or	Quad	mus-
cles,	but	generally	declines	by	24	months	of	age.	In	contrast,	while	
muscle mass is not different between control and i-mn-Sod1KO	mice	
at	11	months	of	age,	muscle	masses	for	 i-mn-Sod1KO	mice	decline	
by	16	months	in	all	cases.	Furthermore,	for	both	TA	and	Quad	mus-
cles a steady decline in mass occurs throughout all of the ages stud-
ied.	These	findings	indicate	that	the	reduction	in	CuZnSOD	levels	in	
motor neurons can impact a number of hind limb muscles tending to 
accelerate the reduction in muscle mass that occurs with age.
To probe the molecular changes associated with loss of muscle 
mass,	we	measured	the	expression	of	several	genes	associated	with	
protein	breakdown	as	 shown	 in	Figure	4c.	We	measured	a	 signifi-
cant	 increase	 in	atrogin-1	 (2.5-fold)	 in	24-month-old	 i-mn-Sod1KO	
mice	 compared	 to	 control	mice,	with	no	 change	 in	 the	expression	
of	MURF1	 (Figure	4c).	Despite	 the	 lack	of	change	 in	gene	expres-
sion	in	muscle	from	older	i-mn-Sod1KO	mice,	the	protein	expression	
of	MURF1	was	significantly	upregulated	 (2.4-fold)	 in	 i-mn-Sod1KO	
mice	muscle	 (Figure	S2).	Analysis	of	transcript	 levels	of	markers	of	
autophagy	 showed	 a	 significant	 increase	 in	 LC3	 (1.9-fold),	 p62	 (2-
fold),	and	BNIP3	(1.93-fold)	in	muscle	from	i-mn-Sod1KO	mice	com-
pared	with	control	mice	(Figure	4c).
3.5  |  Age-associated decline in force generation is 
accelerated and exacerbated in i-mn-Sod1KO mice in 
older mice
Based	 on	 the	 observation	 that	 compared	 with	 muscles	 of	 control	
mice,	 muscles	 of	 i-mn-Sod1KO	 mice	 show	 increased	 NMJ	 disrup-
tion,	we	tested	whether	there	was	an	effect	on	force	generation	 in	
response	 to	 nerve	 stimulation.	 Consistent	 with	 smaller	 masses	 of	
GTN	muscles	in	i-mn-Sod1KO	compared	with	control	mice,	maximum	
isometric	force	(Po)	is	significantly	lower	for	muscles	of	i-mn-Sod1KO	
mice	compared	with	wild-type	tamoxifen	 injected	control	values	by	
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16	months	in	female	mice	(Figure	5a)	and	slightly	later	(by	24	months)	
in	male	mice	(Figure	5b).	The	 lower	Po	at	16	months	 in	female	mice	
is not associated with a decrease in specific force indicating that the 
lower force is due entirely to muscle atrophy with no difference in 
the	quality	of	 the	muscle	 in	 terms	of	 force-generating	 capacity.	By	
24	months,	muscles	 of	 i-mn-Sod1KO	mice	 displayed	 lower	 specific	
forces	compared	with	wild-type	mice	for	both	female	and	male	mice	
(Figure	5a,b).	Based	on	the	observation	that	65%	of	the	NMJs	in	GTN	
muscles of i-mn-Sod1KO	mice	appeared	either	partially	or	fully	den-
ervated	at	24	months	(Figure	3b),	we	hypothesized	that	at	least	a	por-
tion	of	the	weakness	of	muscles	in	i-mn-Sod1KO	mice	we	observed	at	
that age in response to activation through the nerve was due to func-
tionally	denervated	NMJs	that	did	not	transmit	an	action	potential	to	
the	muscle	to	generate	contraction.	To	test	this	hypothesis,	we	tested	
whether	any	of	the	weakness	could	be	rescued	when	the	muscle	was	
activated	 by	 direct	 muscle	 stimulation,	 bypassing	 the	 requirement	
for	 a	 functional	NMJ.	No	 differences	were	 observed	 for	wild-type	
mice	in	maximum	force	generation	using	either	nerve	stimulation	or	
direct	muscle	stimulation	indicating	that	the	NMJs	in	wild-type	mus-
cles were largely functionally intact and capable of transmitting an 
action	potential	(Figure	5c).	In	contrast,	force	was	increased	~30%	in	
i-mn-Sod1KO	mice	when	the	NMJ	was	bypassed	and	muscles	were	
activated	 directly	 indicating	 that	 a	 substantial	 number	 of	 NMJs	 in	
i-mn-Sod1KO	mice	did	not	 transmit	a	nerve	action	potential	 to	 the	
muscle	fiber,	although	the	muscle	fibers	could	be	activated	directly	to	
contract.	These	data	show	that	reduction	of	CuZnSOD	in	neurons	re-
sults	in	the	development	over	time	of	functionally	denervated	NMJs.
3.6  |  Muscle mitochondrial function is not altered 
in i-mn-Sod1KO mice, even at later ages
We	have	previously	shown	that	peroxide	generation	from	mitochon-
dria	 is	 strongly	 correlated	 to	 denervation-induced	muscle	 atrophy	
(Muller	et	al.,	2007).	Here,	we	measured	mitochondrial	oxygen	con-
sumption	and	peroxide	generation	simultaneously	using	permeabi-
lized	muscle	fibers	from	GTN	muscles.	Mitochondrial	respiration	and	
rates	of	hydrogen	peroxide	generation	are	not	different	 in	muscle	
from	control	and	i-mn-Sod1KO	mice,	even	in	fibers	isolated	from	24-	
to	28-month-old	mice	(Figure	6a,b).	To	confirm	that	the	mitochon-
drial number did not vary significantly between muscle fibers from 
control and i-mn-Sod1KO	mice,	we	measured	expression	of	VDAC,	
an	 outer	mitochondrial	membrane	protein	 by	Western	 blot	 analy-
sis.	The	data	 in	Figure	S3	show	similar	 levels	of	VDAC	expression,	
supporting a similar mitochondrial content between the two groups. 
We	also	measured	expression	of	a	subset	of	genes	representative	of	
subunits	present	in	electron	transport	chain	Complexes	I–V	in	GTN	
muscle	from	the	older	mice.	Several	of	the	genes	show	lower	mRNA	
expression	 in	 the	muscle	 from	24-	 to	 26-month-old	 i-mn-Sod1KO	
mice	(Figure	6C)	suggesting	a	possible	impact	on	mitochondria	de-
spite	the	lack	of	a	measureable	reduction	in	function.
3.7  |  Oxidative damage
F2-Isoprostanes	are	a	sensitive	and	reliable	marker	of	oxidative	stress.	
We	measured	the	F2-isoprostanes	 in	quadriceps	muscle	 from	con-
trol and i-mn-Sod1KO	mice	(Figure	6d).	The	level	of	F2-isoprostanes	
is	 increased	by	94%	in	muscle	tissue	from	the	10-month-old	 i-mn-
Sod1KO	mice	compared	with	age-matched	control	mice	(NS,	p	<	.06))	
and	by	111%	in	the	18-	to	22-month-old	mice	compared	with	young	
control	mice	(p	<	.05).	In	the	18-	to	22-month-old	group,	the	 i-mn-
Sod1KO	mice	have	a	59%	increase	 in	F2-isoprostanes.	Surprisingly	
however,	we	did	not	find	an	increase	in	protein	carbonylation	in	the	
18-	to	22-month-old	i-mn-Sod1KO	mice	(Figure	6d).
4  |  DISCUSSION
The	major	finding	of	this	study	is	that	reduced	expression	of	the	super-
oxide	scavenger	CuZnSOD	in	neuronal	tissue,	initiated	postdevelopment	
in	adult	mice,	results	in	an	early	loss	of	alpha	motor	neurons	in	the	ven-
tral	spinal	cord,	followed	by	a	later	disruption	of	neuromuscular	junctions	
and	muscle	atrophy	and	weakness	in	the	older	mice.	Thus,	while	the	re-
duction	in	CuZnSOD	protein	expression	induced	after	development	(at	
2–4	months	of	age)	restricted	to	neurons	does	 indeed	eventually	 lead	
to	 increased	muscle	 atrophy	 and	weakness,	 this	 effect	 is	 not	 evident	
until	the	mice	are	between	16	and	22	months	of	age	(more	than	1	year	
after	deletion	of	the	gene	with	tamoxifen).	The	delay	in	the	presentation	
of muscle atrophy is observed despite alpha motor neuron loss being 
evident within a few months after Sod1 deletion. These data support 
a critical role for innervation in maintaining muscle mass and strength 
with age but also indicate a robust ability of the neuromuscular system 
to	exploit	compensatory	mechanisms	to	delay	the	development	of	the	
sarcopenia phenotype. The findings further suggest that muscle loss 
and	weakness	manifest	 only	 once	 the	 compensatory	mechanisms	 are	
exhausted	or	after	the	onset	of	additional	intrinsic	aging	effects	in	the	
neurons	or	muscle	 tissue.	This	 “two	hit”	hypothesis	suggests	 that	 loss	
of	motor	neurons	will	initiate	muscle	degeneration,	but	that	the	critical	
threshold	for	NMJ	disruption	and	atrophy	requires	a	“second	hit”.	While	
F I G U R E  1   Characterization	of	the	i-mn-Sod1KO	model.	(a)	Representative	Western	blot	analysis	of	CuZnSOD	expression	in	neuronal	
and	non-neuronal	tissues	(brain,	spinal	cord,	sciatic	nerve,	and	gastrocnemius	muscle)	in	10-month-old	and	18-	to	22-month-old	wild-type	
and i-mn-Sod1 KO	mice	(n	=	3–5	per	group,	mixed	male	and	female).	Mice	were	injected	with	tamoxifen	at	2–4	months	of	age.	(b)	Graphical	
representation	of	quantified	blots,	normalized	to	β-actin	or	Ponceau	stain.	Bars	represent	mean	±	SEM	(n	=	3–5	per	group)	and	are	expressed	
relative	to	wild-type	control	value	for	each	age	group.	Student's	unpaired	t	test,	*p	≤	.05.	(c)	Representative	image	of	immunofluorescence	
staining	of	spinal	cord	lumbar	region	from	control	(10-month-old,	top	panel),	Sod1KO	(10-month-old,	middle	panel)	and	i-mn-Sod1KO	mice	
(10-month-old,	bottom	panel)	with	DAPI	(blue,	first	panel),	NeuN	(green,	second	panel),	CuZnSOD	(red,	third	panel).	A	merged	image	of	
DAPI,	NeuN,	and	CuZnSOD	is	given	in	panel	4.	Scale	50	µm,	magnification	20×
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our	experiments	implicate	motor	neuron	death	as	the	first	hit,	the	sub-
stantial delay between a measureable loss of motor neurons from the 
spinal cord and its manifestation as muscle atrophy indicates that there 
are compensatory mechanisms that protect the muscle from denerva-
tion-induced	 fiber	 loss.	The	 nature	 of	 the	 compensatory	mechanisms	
are	not	clear,	but	it	 is	reasonable	to	hypothesize	that	failure	of	one	or	
more of these compensatory mechanisms represents the second hit. The 
compensatory	mechanisms	clearly	must	facilitate	motor	unit	remodeling,	
that	is,	axonal	branching	from	innervated	motor	units	that	rescue	fibers	
in	denervated	motor	units.	Thus,	protective	compensatory	mechanisms	
likely	include	factors	that	contribute	to	the	maintenance	of	the	ability	of	
axonal	sprouts	to	form,	grow	and	be	guided	to	denervated	myofibers	as	
well as facilitating the receptiveness of denervated myofibers to form 
and	maintain	 stable	 “new”	NMJs.	Other	 experiments	 from	 our	 group	
show that restoration of postsynaptic cellular functions in Sod1KO	mice,	
such as calcium handling by the myofibers and preservation of mitochon-
drial	function,	is	also	protective	of	muscle	mass	and	function	and	thus	
could	be	argued	as	the	second	hit.	Finally,	we	and	others	have	reported	
that adaptive responses in muscle following denervation eventually fail 
(Chipman,	 Schachner,	 &	 Rafuse,	 2014;	 Scalabrin	 et	 al.,	 2019;	Vasilaki	
et	 al.,	 2010).	Thus,	 the	 second	hit	may	 involve	 the	muscle	 reaching	a	
threshold	past	which	it	no	longer	maintains	NMJ	structure	and	function	
allowing downstream effects of muscle mass and function to occur. 
Alternatively,	the	remaining	motor	neurons	may	reach	a	threshold	past	
which	they	cannot	maintain	increasing	motor	unit	size	resulting	in	fur-
ther	denervation	and	atrophy.	Of	course,	some	combination	of	these	two	
possibilities could also collectively provide the second hit.
In	an	earlier	study,	we	reported	that	reduction	of	CuZnSOD	in	
Sod1	floxed	mice	using	Cre	 recombinase	expression	driven	by	 the	
promoter	 for	 nestin	 (n-Sod1KO	mice)	 resulted	 in	 only	 a	 very	mild	
NMJ	 phenotype,	 a	 very	 slight	 reduction	 in	 force	 generation	 and	
no atrophy in the gastrocnemius muscle even at 20 months of age 
(Sataranatarajan	et	al.,	2015).	These	results	were	intriguing	and	sug-
gested that a phenotype was potentially developing but not com-
plete	in	these	mice.	In	retrospect,	we	considered	whether	the	results	
were	directly	related	to	our	choice	of	Cre	recombinase	model.	The	
nestin-Cre	model	is	a	constitutively	expressed	Cre	recombinase	that	
would direct deletion of Sod1 beginning early in embryonic develop-
ment and persist throughout the lifespan. The nestin protein is an 
intermediate	 filament	 protein	 and	 component	 of	 the	 cytoskeleton	
in	neural	stem	cells	that	is	also	known	to	be	expressed	in	a	number	
of	non-neuronal	tissues,	including	muscle	satellite	stem	cells	(Bernal	
&	Arranz,	2018).	Thus,	the	induction	of	Sod1 deletion in this model 
would not only have been initiated early in development but would 
F I G U R E  2   Reduced motor neuron number and motor coordination in i-mn-Sod1 KO	mice.	(a)	Representative	image	showing	NeuN	
immunostaining	(green)	in	young	(10	months)	and	old	(18–22	months)	wild-type	control	(top	panel)	and	i-mn-Sod1-KO	mice	(bottom	panel).	
A	transverse	section	of	lumbar	region	of	spinal	cord	was	used	for	staining.	Scale	200	µm,	magnification	20×.	(b)	Quantification	of	motor	
neuron	numbers	from	the	lumbar	region	of	spinal	cord	of	young	(10	months)	and	old	(18–22	months)	in	control	and	i-mn-Sod1KO	mice	
(n	=	3–4	mice/group).	*Significantly	different	from	10-month	control	and	(#)	from	18-	to	22-month	control	by	one-way	ANOVA	(p	<	.05)	(c)	
Quantification	of	motor	neuron	area	from	young	(10	month)	control	and	i-mn-Sod1KO	mice	(n	=	4	mice/group)	*Significantly	different	from	
control	by	Student's	t	test	(p	<	.05).	(d)	Loss	of	hind	limb	extension	reflex	i-mn-Sod1KO	mice.	Representative	pictures	illustrating	the	hind	
limb	clasping	reflex	in	22-month-old	control	(left)	and	i-mn-Sod1KO	mice	(right)
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F I G U R E  3   Neuromuscular	junction	(NMJ)	morphology.	(a)	Representative	images	of	NMJs	in	gastrocnemius	muscles	of	24-month-old	
WT	and	i-mn-Sod1KO	mice.	Expanded	insets	at	top	correspond	to	respective	boxed	NMJs	below	and	display	some	of	the	more	dramatic	
differences	observed	between	24-month-old	WT	and	i-mn-Sod1KO.	Note	the	decreased	complexity,	lack	of	innervation,	and	increased	
endplate fragmentation in i-mn-Sod1KO.	(b)	Quantification	of	NMJs	in	which	pre-	and	postsynaptic	structures	show	full	overlap	(Innervated),	
partial	overlap	(Partially	Innervated),	and	no	overlap	(Denervated).	Four	muscles	per	group	were	analyzed	and	approximately	100	endplates	
were evaluated for each muscle. Data are presented as means ± SD.	Differences	between	experimental	groups	for	each	state	if	innervation	
is	shown	with	*	indicating	differences	from	all	other	groups	and	#	also	different	from	all	other	groups,	that	is,	a	significant	increase	in	
denervated	NMJs	is	observed	by	24	months	in	WT	mice	that	was	more	severe	in	i-mn-Sod1KO	mice.	(c)	Quantification	of	mRNA	for	AchR	
alpha	relative	to	18S	RNA	using	real-time	PCR	analysis.	Values	represent	mean	±	SEM.	*Different	from	wild-type	control	by	Student's	t test 
(p	<	.05).	n	=	9–11	(male	and	female)
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potentially have resulted in Sod1 deletion in other tissues as well. 
For	these	reasons,	in	the	current	study	we	used	an	alternative	Cre	
model,	a	motor	neuron	targeted	Cre	recombinase	(Slick	H	Cre)	and	
initiated	 the	deletion	 in	 young	adult	mice.	Although	 the	extent	of	
deletion	we	detected	 in	the	brain,	spinal	cord,	and	sciatic	nerve	 in	
the i-mn-Sod1KO	mice	was	slightly	less	than	the	deletion	we	previ-
ously	achieved	in	the	nestin-Cre	Sod1	deletion	model,	the	deletion	
of Sod1	 in	the	motor	neurons	 in	the	Slick	H	Cre	model	appears	to	
be	very	good,	as	demonstrated	by	our	staining	of	motor	neurons	in	
the	 ventral	 spinal	 cord.	Moreover,	 one	would	 not	 anticipate	more	
pronounced evidence of whole tissue deletion based on the hetero-
geneity of cell types present in these tissues. The deletion of Sod1 
targeted to neurons is a major advantage of this model and allows us 
to more definitely test the role of neuron versus muscle in the initia-
tion	and	development	of	muscle	atrophy	and	weakness.
To	verify	the	response	to	the	Slick	H	Cre	recombinase,	we	mea-
sured motor neuron counts in the ventral horn of the lumbar spinal 
cord	and	found	a	significant	loss	of	motor	neuron	number,	decreased	
motor	neuron	area,	and	clasping	behavior	in	response	to	tail	suspen-
sion in the i-mn-Sod1KO	mice	compared	with	control	mice,	all	pheno-
types	consistent	with	neuronal	degenerative	processes.	By	10	months	
of	age	(i.e.,	6–8	months	after	Sod1	gene	deletion),	the	 i-mn-Sod1KO	
mice	showed	a	28%	loss	in	alpha	motor	neurons	compared	with	age-
matched	wild-type	mice	that	was	even	greater	(over	50%)	in	the	older	
i-mn-Sod1KO	mice.	A	 significant	 age-related	 loss	of	motor	neurons	
was	also	evident	by	18	to	22	months	in	control	mice.	Consistent	with	
these	data,	we	previously	measured	motor	neuron	counts	 in	young	
(3-	to	6-month-old)	versus	old	wild-type	(24	to	27	month)	C57Bl6	J	
mice	 and	 reported	a	 similar	 (41%)	decline	 in	motor	neuron	number	
with	 age	 (Piekarz	 et	 al.,	 2020).	 These	 findings	 support	 a	 role	 for	
F I G U R E  4   Analysis	of	gastrocnemius	muscle	mass	in	male	and	female	wild-type	and	i-mn-Sod1KO	mice	as	a	function	of	age.	(a)	
Gastrocnemius	muscle	mass	relative	to	body	mass	at	6–11-months	(n	=	23	female	WT;	4	male	WT;	39	i-mn-Sod1KO	females;	6	i-mn-SodKO	
males),	16–22-months	(n	=	16	female	WT;	10	male	WT;	37	i-mn-Sod1KO	females;	14	i-mn-SodKO	males)	and	in	24-	to	26-month-old	males	
(n	=	21	WT	and	21	i-mn-Sod1KO	mice).	*Difference	between	marked	groups	detected	using	one	way	ANOVA	(p	<	.05)	Data	represent	
mean ± SEM	for	each	group.	Females	are	shown	in	blue	and	males	in	red.	(b)	Quantification	of	mRNA	expression	in	gastrocnemius	muscle	
tissue	from	24-month-old	control	and	i-mn-Sod1	KO	mice	(n	=	5–8)	for	Atrogin-1,	MURF1,	LC3,	BNIP3,	and	P62	(b)
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oxidative	stress-induced	neuron	loss	in	the	spinal	cord	of	the	young	
i-mn-Sod1KO	mice	that	is	exacerbated	as	a	function	of	age.
CuZnSOD	protein	is	very	high	in	neuronal	tissue	(0.5%	of	total	
protein),	and	it	likely	is	critical	for	maintaining	redox	balance	in	neu-
rons	(Troy	&	Shelanski,	1994).	Mice	lacking	CuZnSOD	are	known	to	
exhibit	progressive	motor	axonopathy	and	severe	mitochondrial	ox-
idation	in	neurons	(Fischer,	Li,	Asress,	Jones,	&	Glass,	2012).	In	ad-
dition,	motor	neurons	are	very	sensitive	to	oxidative	stress-induced	
pathology	 (Gilgun-Sherki,	Melamed,	&	Offen,	2001)	and	 increased	
oxidative	 stress	 in	 neurons	 is	 a	 contributing	 factor	 for	 pathogen-
esis	 of	 several	 neurological	 disease	 such	 as	 Alzheimer's	 disease,	
Parkinson	 disease,	 Huntington's	 disease,	 and	 amyotrophic	 lateral	
sclerosis	 (Kim,	 Kim,	 Rhie,	 &	 Yoon,	 2015;	 Paloczi,	 Varga,	 Hasko,	 &	
Pacher,	2018;	Shaw	&	Eggett,	2000).	It	has	also	been	reported	that	
CuZnSOD	 protein	 expression	 is	 high	 in	 motor	 neurons	 compared	
with	 other	 neurons,	 suggesting	 the	 importance	 of	 CuZnSOD	 in	
motor	 neurons	 (Bergeron,	 Petrunka,	&	Weyer,	 1996).	 Importantly,	
Sod1 deficient neurons are more susceptible to cell death due to 
axotomy	 (Reaume	 et	 al.,	 1996)	 ischemia	 (Kondo	 et	 al.,	 1997),	 and	
glutamate	excitotoxicity	(Schwartz,	Reaume,	Scott,	&	Coyle,	1998).	
Consistent	 with	 the	 impact	 of	 oxidative	 stress	 in	 motor	 neurons,	
conditional	motor	neuron	deletion	of	glutathione	peroxide	4	(GPX4),	
another	 antioxidant	 enzyme	 that	 functions	 to	 remove	 lipid	 per-
oxide-induced	 damage,	 also	 leads	 to	 severe	 atrophy	 and	 paralysis	
(Chen	et	al.,	2015).	Finally,	in	a	previous	study	we	showed	that	neu-
ron-specific	 expression	 of	 Sod1	 in	whole-body	 knockout	mice	 for	
CuZnSOD	(Sod1−/−	mice)	prevented	the	accelerated	muscle	atrophy	
and	NMJ	disruption	phenotype	 in	 these	mice,	 and	 improved	mus-
cle	 function	 (Sakellariou	et	al.,	2014).	 It	 is	 interesting	 to	note	here	
that	our	data	from	that	study	indicated	that	approximately	20%	of	
F I G U R E  5   Force	generation	by	gastrocnemius	(GTN)	muscles.	Maximum	isometric	force	expressed	in	milli-newtons	(mN)	and	maximum	
force	normalized	by	total	muscle	fiber	cross-sectional	area	(N/cm2)	for	muscles	of	(a)	female	and	(b)	male	mice	with	muscles	activated	
by stimulation of the nerve. Deficits in absolute force generation for muscles of i-mn-Sod1KO	compared	with	wild-type	(WT)	mice	were	
observed	in	female	mice	by	16	months	that	were	explained	by	loss	of	muscle	mass	(i.e.,	no	deficit	in	specific	force).	Both	female	and	male	
mice	showed	deficits	in	specific	force	by	24	months	of	age.	(c)	The	magnitude	of	the	increase	in	force	(%	of	values	shown	in	panels	a	and	b)	
when	muscles	of	24-	to	26-month-old	mice	were	activated	by	direct	muscle	stimulation.	These	data	indicate	that	a	portion	of	the	specific	
force deficit in i-mn-Sod1KO	mice	is	due	to	the	presence	of	functionally	denervated	muscle	fibers	with	NMJs	that	do	not	transmit	an	action	
potential.	Data	are	expressed	as	mean	±	SD	and	*significant	difference	from	WT	values	at	the	same	age
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the	endogenous	mouse	CuZnSOD	protein	had	been	replaced	with	
human	CuZnSOD,	suggesting	that	even	a	small	amount	of	CuZnSOD	
is sufficient to protect motor neurons and prevent atrophy. In the 
current	study,	the	later	development	of	the	phenotype	of	NMJ	dis-
ruption,	atrophy,	and	weakness	suggests	 that	we	have	deletion	of	
Sod1	from	most,	but	perhaps	not	all	alpha	motor	neurons.	It	is	feasi-
ble	that	this	residual	CuZnSOD	activity	contributes	to	the	mitigation	
of	the	phenotype	in	middle	age	and	delay	in	NMJ	disruption,	atro-
phy,	and	weakness	until	later	in	the	lifespan.	Together	these	findings,	
all	support	the	fact	that	elevated	oxidative	stress	in	motor	neurons	is	
highly	correlated	to	muscle	atrophy	and	degeneration,	although	the	
sequence	of	events	leading	from	neuronal	stress	to	NMJ	disruption	
and	atrophy	and	weakness	remain	to	be	clearly	defined.
Loss	of	innervation	in	skeletal	muscle	could	occur	through	changes	
in the neurons that lead to retraction of neurons from the acetylcho-
line receptor or changes in the postsynaptic components of the neu-
romuscular	 junction,	 the	 ultimate	 connection	 between	 neuronal	 and	
muscle	tissue.	Disruption	of	NMJ	structure	and	function	is	a	hallmark	
of aging in humans and rodent models and is associated with sarcopenia 
(Jackson	&	McArdle,	2016;	Jang	et	al.,	2012;	McArdle,	Pollock,	Staunton,	
&	Jackson,	2019;	Valdez	et	al.,	2010;	Vasilaki	et	 al.,	2016,	2017)	and	
several	neurological	disorders	including	ALS	(Gould	et	al.,	2006;	Valdez,	
Tapia,	Lichtman,	Fox,	&	Sanes,	2012).	We	show	here	that	targeted	dele-
tion of Sod1	in	motor	neurons	results	in	nearly	70%	of	junctions	showing	
complete	or	partial	denervation	by	24	months	of	age,	although	only	22%	
are	fully	denervated.	This	is	far	less	than	the	extent	of	denervation	we	
have previously reported in the Sod1−/−	mice	where	by	18–20	months	
of	age	80%	of	the	synapses	are	denervated	(Jang	et	al.,	2010).	An	ad-
ditional point that should be considered is that we do not completely 
understand	the	relationship	between	the	morphology	of	the	NMJ	and	
its	functional	capacity.	It	is	possible	that	some	percentage	of	the	NMJs	
that appear normal are not completely functional or vice versa.
Our previous studies also show a clear connection between loss 
of	innervation	and	increased	generation	of	peroxides	from	mitochon-
dria that could contribute to the downstream initiation and progres-
sion of muscle degeneration and atrophy as well as changes in force 
generation.	We	show	here	that	the	i-mn-Sod1KO	mice	do	not	show	
changes	in	oxygen	consumption	or	mitochondrial	peroxide	genera-
tion	even	in	the	older	mice,	suggesting	the	loss	of	innervation	is	not	
extensive	enough	to	cause	peroxide	generation	in	the	i-mn-Sod1KO	
mice.	We	do	however	see	some	evidence	of	mitochondrial	stress	in	
muscle of the old i-mn-Sod1KO	mice	as	shown	in	the	reduced	level	
of	 electron	 transport	 chain	 complexes.	 It	 is	 possible	 that	 the	 lack	
of mitochondrial phenotype is related to a compensation by the re-
maining	 fibers	 that	 do	 not	 drop	 out	 in	 response	 to	 loss	 of	NMJS.	
This	has	been	shown	for	example,	in	a	mouse	model	of	Amyotrophic	
Lateral	Sclerosis	(ALS),	where	there	is	a	dramatic	loss	of	NMJs	and	
a	preferential	loss	of	Type	IIB	fast	fibers	while	the	remaining	fibers	
become	 stronger	 and	 more	 fatigue	 resistant	 (Hegedus,	 Putman,	
Tyreman,	&	Gordon,	 2008).	On	 the	 other	 hand,	 it	 is	 possible	 that	
atrophy is due largely to fiber loss and the fibers that remain have 
sufficiently	intact	NMJs	to	maintain	postsynaptic	functions.
We	measured	F2-isoprostanes	as	a	measure	of	oxidative	damage	
that is often associated with muscle atrophy in aging. Despite the 
lack	 of	mitochondrial	 peroxide	 generation	 in	 the	muscle	 from	 the	
i-mn-Sod1KO	mice,	F2-isoprostane	levels	are	increased	in	both	the	
young and older cohorts of i-mn-Sod1ko	mice	and	correlate	roughly	
with	extent	of	loss	of	muscle	mass.	This	result	suggests	the	absence	
of	CuZnSOD	in	motor	neurons	leads	to	increased	oxidative	stress	in	
skeletal	muscle	that	is	not	generated	by	the	mitochondria.
In	conclusion,	our	findings	show	that	oxidative	stress	induced	by	
deletion	of	CuZnSOD	can	effectively	initiate	loss	of	motor	neurons	
within a fairly short time frame after deletion that progresses with 
age.	 In	contrast,	 the	downstream	phenotypes	associated	with	sar-
copenia,	that	is,	NMJ	disruption,	muscle	atrophy,	and	weakness,	all	
appear	later,	with	a	significant	delay	after	motor	neuron	deletion	of	
CuZnSOD.	It	takes	several	months	before	the	deletion	of	CuZnSOD	
from	 motor	 neurons	 leads	 to	 NMJ	 disruption,	 suggesting	 there	
is	 a	 threshold	 reached,	 past	which	 the	muscle	 and	neuron	 cannot	
maintain	 intact	 NMJs.	Muscle	 atrophy	 and	weakness	 also	 appear	
on	this	delayed	time	frame,	again	supporting	a	threshold	effect	or	
requirement for a second hit in addition to motor neuron deficits. In 
addition,	we	expect	that	the	surviving	motor	neurons	expand	their	
axonal	arbors	based	on	previous	studies	in	nerve	injury,	partial	de-
nervation,	and	in	aging	where	significant	expansion	of	motor	units	
occurs. These findings support an important role for motor neurons 
in initiating muscle degeneration but implicate the possibility of a 
requirement for an accumulation of damage postsynaptically before 
the	full	phenotype	develops.	Our	future	studies	will	seek	to	define	
the critical factors that contribute to the threshold effect.
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